Carlos Perez-Martinez

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.

The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.

Journal: Expert review of molecular diagnostics

Published: August 05, 2026

The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.

The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.

Journal: Expert review of molecular diagnostics

Published: August 05, 2026

The Iberian fossil record of †Otodus megalodon rejects Mediterranean dwarfism and supports nursery use.

The Iberian fossil record of †Otodus megalodon rejects Mediterranean dwarfism and supports nursery use.

Journal: Biology letters

Published: October 02, 2025

Corrigendum: Comparative analysis of the development of acquired radioresistance in canine and human mammary cancer cell lines.

Corrigendum: Comparative analysis of the development of acquired radioresistance in canine and human mammary cancer cell lines.

Journal: Frontiers in veterinary science

Published: April 21, 2025

The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer.

The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer.

Journal: Journal of personalized medicine

Published: August 29, 2023

Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer.

Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer.

Journal: Expert review of anticancer therapy

Published: January 12, 2023

The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer.

The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer.

Journal: Journal of personalized medicine

Published: September 29, 2021

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer.

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 02, 2021

A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer.

A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer.

Journal: Journal of personalized medicine

Published: July 29, 2021

Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine.

Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine.

Journal: Journal of personalized medicine

Published: June 14, 2021

The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer.

The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer.

Journal: Journal of personalized medicine

Published: June 08, 2021

Current trends in the treatment of HR+/HER2+ breast cancer.

Current trends in the treatment of HR+/HER2+ breast cancer.

Journal: Future oncology (London, England)

Published: March 17, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026